Jaguar Health Inc.

NASDAQ: JAGX · Real-Time Price · USD
2.08
0.01 (0.48%)
At close: Aug 15, 2025, 3:59 PM
2.12
1.68%
After-hours: Aug 15, 2025, 07:45 PM EDT

Jaguar Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.17M 3.51M 3.11M 2.72M 2.35M 2.3M 2.81M 2.68M 1.97M 3.26M 3.15M 2.92M 2.63M 2.08M 630K 385K 1.24M
Cost of Revenue
515K 557K 541K 427K 1.04M 1.28M 514K 491K 345K 495K 613K 456K 455K 469K 617K 664K 583K
Gross Profit
1.66M 2.95M 2.57M 2.29M 1.31M 1.02M 2.3M 2.19M 1.63M 2.77M 2.54M 2.46M 2.17M 1.61M 13K -279K 658K
Operating Income
-9.42M -8.16M -7.26M -7.2M -8.21M -7.19M -8.79M -8.1M -9.85M -6.29M -9.9M -6.48M -11.75M -10.82M -9.53M -11.58M -8.77M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-10.6M -10.23M -10.02M -9.63M -9.37M -9.31M -7.9M -12.29M -12.4M -8.23M -12.61M -9.39M -18.16M -14.32M -12.19M -14.08M -12.01M
Net Income
-10.46M -9.92M -9.85M -9.49M -9.23M -9.17M -7.78M -12.15M -12.2M -7.38M -12.52M -9.37M -17.99M -14.31M -12.19M -14.08M -12.01M
Selling & General & Admin
7.39M 6.58M 5.79M 5.84M 5.82M 4.75M 5M 6.01M 6.7M 4.74M 6.49M 6.49M 8.98M 6.95M 6.23M 7.26M 5.55M
Research & Development
3.73M 4.53M 4.04M 3.65M 4.31M 3.46M 6.08M 4.28M 4.78M 4.31M 5.94M 2.45M 4.95M 5.48M 3.31M 3.87M 2.41M
Other Expenses
n/a n/a n/a n/a 234K n/a -70K 26K -12K n/a n/a n/a n/a n/a -20K -17K 10K
Operating Expenses
11.12M 11.11M 9.83M 9.49M 9.53M 8.21M 11.09M 10.29M 11.47M 9.05M 12.43M 8.94M 13.92M 12.43M 9.54M 11.13M 7.96M
Interest Expense
56K n/a n/a n/a 611K 248K 500K 3.45M 2.18M 2.63M 2.73M 2.54M 4.19M 2.43M 2.08M 2.01M 1.9M
Selling & Marketing Expenses
2.49M 1.54M 2.01M 1.52M 661K 1.53M 637K 878K 1.88M 1.75M 2.11M 1.34M 2.83M 2.3M 2.26M 2.19M 2.14M
Cost & Expenses
11.63M 11.67M 10.37M 9.92M 10.57M 9.49M 11.6M 10.78M 11.82M 9.55M 13.05M 9.4M 14.38M 12.9M 10.16M 11.79M 8.54M
Income Tax Expense
-132K n/a n/a n/a n/a -139K n/a n/a n/a -852K -89K -23K -178K -5K n/a n/a n/a
Shares Outstanding (Basic)
626.64K 294.53K 374.81K 93.98K 1.77K 15.42K 13.86K 11.79K 3.42K 11.69 12.64 9.52 6.93 5.45 5.36 1.77 1.66
Shares Outstanding (Diluted)
626.64K 294.53K 374.81K 93.98K 1.77K 15.42K 13.86K 19.46K 3.42K 11.69 12.64 9.52 6.93 5.45 5.45 1.78 1.69
EPS (Basic)
-16.7 -33.68 -26.25 -101 -5.22K -600 -570 -1.03K -3.58K -633.38K -993.38K -986.63K -2.6M -2.63M -2.28M -7.95M -7.27M
EPS (Diluted)
-16.7 -33.68 -26.25 -101 -5.22K -600 -570 -630 -3.58K -633.38K -993.38K -986.63K -2.6M -2.63M -2.24M -7.91M -7.13M
EBITDA
-9.42M -15.75M -6.67M -6.64M -8.15M -8.47M -6.78M -7.48M -9.66M -5M -9.29M -6.21M -13.52M -12.17M -9.64M -11.64M -9.68M
EBIT
n/a -16.35M -7.26M -7.2M -8.76M -7.19M -7.4M -8.1M -10.22M -5.6M -9.88M -6.85M -13.97M -11.88M -10.11M -12.07M -10.11M
Depreciation & Amortization
n/a 593K 596K 559K 610K 591K 625K 621K 551K 602K 587K 648K 455K 492K 473K 431K 431K